Japan and the US held a new round of talks yesterday on mad cow testing standards as the trading partners try to untangle a four-month dispute that has shut American beef out of its most lucrative export market.
At the first such meeting since January, officials were reportedly set to agree to a new structure for pursuing negotiations but weren't expected to break a deadlock over whether US testing standards are adequate.
A series of visiting US delegations have failed to persuade Japan's government to lift a ban imposed on American beef imports after a single case of mad cow disease was detected in Washington state in late December.
Japan has said it will not resume imports unless the US requires all 35 million cattle it slaughters annually to be tested for mad cow disease. US agriculture officials say there's no scientific reason to test every animal.
Media reports said the two sides would agree at yesterday's meeting to set up an experts group to discuss testing methods and other technical issues related to the trade tussle.
Japanese officials started the talks by stating that ensuring consumers' safety was the prerequisite for letting US beef back in, national broadcaster NHK said.
The US trade delegation was led by US Agriculture Undersecretary J.B. Penn.
Japan's small beef industry adopted a policy of testing every cow slaughtered after an outbreak of mad cow disease here in 2001. The US plans to test at least 220,000 cattle by the end of 2005 under an expanded surveillance program targeting animals over 30 months old, and others deemed most at risk.
Japan has refused to accept a US proposal for international mediation on the ban. The proposal called for both nations to present arguments before a panel of the World Organization for Animal Health.
People who eat beef tainted by the aberrant protein that causes mad cow disease, also known as bovine spongiform encephalopathy or BSE, can contract a rare but fatal variant, Creutzfeldt-Jakob disease.
Japan was the most lucrative market for US beef before the import ban, buying almost US$1 billion worth in 2002.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained